Blog / Archives
Rayno Biopharma Portfolio 2018 YTD: Performance Summary
9/10 Update: Long Tesaro (TSRO) We added small positions at $32 on August 21 and more on 9/7 at $35+. =============== Rayno Biopharma Performance 2018: YTD 8/4 Large Caps Begin to Outperform FBT Is...
Q2 Earnings Update: bluebird bio (BLUE) and Regeneron (REGN)
Q2 Earnings Updates: BLUE,REGN Regeneron Pharmaceuticals (REGN) soared 7% to $397 on earnings beat with adjusted EPS of $5.45. U.S.Eyelea sales grew 8% to$992M and global sales grew 13% to $1.66B....
Rayno BioBeat #5: July 2018 Mid-Cap Momentum Fades With Rotation Into Large Caps-Healthcare Stocks Are Strong (XLV)…Updates
Aug 1 Update...overall a good day Hot Mid-Caps: BPMC up 12.18%, NBIX up 13%, SRPT up 3.47% Large Cap Rayno Portfolio Movers: ABBV up 1.82%, BIIB up 2.9%, BMY up 1.48% XLV Flat today after 6.2% run...
Biotechs Sell-Off Last Week: Growth Disappointing or Just Profit Taking? …Updates
Update 7/30 at close- -Large Caps Outperform-Very Weak Tape NASDAQ continues slide down 1.39% Large Cap Leaders ABBV up 0.89%, BMY up 3.53%, CELG up 2.87%,MRK up 2%,REGN up 1.06%, VRTX up 1.35%....
Biotechs Hold and Ignore Rocky Week of Global Politics- Big Earnings Upcoming…Updates CELG, BIIB, AZN, XBI
7/26 We will review all large cap earnings by Saturday 7/28. IBB flat to down over 5 days at $117.87; XBI down 3.2% over 5 days. Technicals do not look good. AstraZeneca (AZN) up 1.9% to $38.15 on...
Biotechs Cruise onto Green Screen: July Looks Good…Updates
Updates: 7/19 pm... Abbvie (ABBV) takes a 4.7% hit on Citron short seller call. Basis for call would be pressure from FDA and Scott Gottlieb concerning stalling by drug companies on biosimilars....
Biotech Rally Buffeted By Trump Tweet But Gains Hold…Update-2
Update-2 ...Futures Sink As Trade War Rhetoric Heats Up: China Responds to Trump Additional $200B in tariffs on Chinese goods that may get hit with tariffs-See Bloomberg updates. China will take...
Biotech Momentum Is Boosted by Biogen’s Alzheimer Disease Drug Results
Biotech Momentum Boosted by Biogen's Experimental Drug Biogen Has an Interesting Pipeline of Medicines for Serious Neurological Diseases Broad Biotech Rally-Green Screen Day- Even Large Caps...
Biotech Bull Market: ETFs and Life Science Mutual Funds 2018 YTD
Biotech Bull Market: Up 25.39% Over 2 Years With High Volatility XBI Outperforms Up 12% YTD; FBT is Comparable, IBB lags. Three Funds did well in H1 2018 (7-9%). Biotech stocks peaked in July 2015...
Rayno BioBeat #4 2018: ASCO Biotech Momentum Continues with M&A Theme…Updates 6/29
Momentous Biotech for June Update 6/28...A nice broad rally on Friday included the large cap biotechs with the IBB up 1.73% to $109.82. Even Celgene (CELG) found buyers up 3.6% flirting with the...